HOME >> BIOLOGY >> NEWS
Interferons effective against smallpox

BALTIMORE March 11, 2003 Proteins produced by the immune system, known as interferons, may be an effective treatment for smallpox, say researchers today at the American Society for Microbiologys Biodefense Research Meeting.

Certain cytokines, particularly interferons, are well known for their antiviral effects in various virus infections, says Ge Liu of Advanced Biosystems, Inc. in Manassas, Virginia, a lead researcher in the study, in collaboration with scientists from the Southern Research Institute in Frederick, Maryland, and George Mason University.

The researchers tested the ability of a number of interferons and interleukins, administered intranasally, to protect mice from a lethal infection with vaccinia virus, a close relative to the smallpox virus that is often used in mice to test potential smallpox treatments. Mice treated with interferons alpha and gamma had survival rates over 95 percent, compared to control groups in which no mice survived.

Intranasal administration of interferon alpha and interferon gamma provides nearly full protection against respiratory vaccinia virus infection in mice, says Liu. Therefore, our results have implications in the utilization of interferon as a prophylactic tool in a scenario of aerosol orthopoxvirus infection.

The American Society for Microbiology (ASM) is the largest single life science society, composed of over 42,000 scientists, teachers, physicians, and health professionals. Its mission is to promote research and training in the microbiological sciences and to assist communication between scientists, policymakers, and the public to improve health, economic well being, and the environment.


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
11-Mar-2003


Page: 1

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Endurance exercise found to be equally effective as diuretics in improving cardiac health
3. Purdue yeast makes ethanol from agricultural waste more effectively
4. Scientists learn how adjuvant makes vaccines effective
5. Super-effective jumping gene created
6. Drug combo effective in advanced breast cancer
7. Data show investigational antibiotic safe, effective in preventing travelers diarrhea
8. Mexican farmers effectively cultivate phenotypic diversity in maize
9. Newer drugs more effective at curing strep throat than penicillin
10. Researchers show chronic sinusitis is immune disorder; antifungal medicine effective treatment
11. Ribozyme package effective against hepatitis B virus

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Interferons effective against smallpox

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: